Ways of improving the efficacy of managing comorbid patients with bronchial asthma in outpatient care practice

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Current study analyzes the problems and strategies for managing comorbid patients with bronchial asthma (BA) in primary care conditions.

The aim: to assess the prevalence and structure of comorbid pathology in patients with controlled and uncontrolled BA clinical course and to develop an algorithm for optimizing therapy based on an integrative approach.

Material and methods. 148 patients with verified diagnosis of BA were examined: 110 of them were with uncontrolled BA and 38 with controlled asthma. All the participants underwent a comprehensive clinical, laboratory, and instrumental examination, along with correction of their baseline therapy and comorbid conditions.

Results. It is shown that uncontrolled BA was significantly associated with a higher frequency and polymorphism of comorbid conditions, including key ones allergic rhinitis (odds ratio (OR) 2.884), gastroesophageal reflux disease (OR 9.066), arterial hypertension (OR 3.728), obesity (OR 4.124), and coronary heart disease (OR 2.674). An integrative management algorithm was developed and tested, including correction of basic BA therapy, targeted treatment of comorbidities, and interdisciplinary collaboration of specialists. Application of this algorithm resulted in disease control in 85.1% of patients.

Conclusion. Personalized approach implemented through an integrative management algorithm is a key condition for improving the efficacy of BA outpatient care and enables disease control in the vast majority of patients.

全文:

受限制的访问

作者简介

Aza Dokhaeva

Stavropol State Medical University of the Ministry of Healthcare of Russia

Email: aza.doxkaeva.94@mail.ru

MD, postgraduate student of the Department of clinical pharmacology with continuing professional education course

俄罗斯联邦, Stavropol

Oksana Pozdnyakova

Stavropol State Medical University of the Ministry of Healthcare of Russia

编辑信件的主要联系方式.
Email: oxana_stav@mail.ru
ORCID iD: 0000-0002-0208-7993
SPIN 代码: 5971-3799

MD, Dr. Sci. (Medicine), professor of the Department of clinical pharmacology with continuing professional education course

俄罗斯联邦, Stavropol

Vladimir Baturin

Stavropol State Medical University of the Ministry of Healthcare of Russia

Email: prof.baturin@gmail.com

MD, Dr. Sci. (Medicine), professor, head of the Department of clinical pharmacology with continuing professional education course

俄罗斯联邦, Stavropol

Natalia Dyshekova

Stavropol State Medical University of the Ministry of Healthcare of Russia

Email: natalia.glebova9@yandex.ru

MD, postgraduate student of the Department of clinical pharmacology with continuing professional education course

俄罗斯联邦, Stavropol

参考

  1. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention, 2024. URL: https://ginasthma.org/ (date of access – 17.09.2025).
  2. Клинические рекомендации. Бронхиальная астма. Российская ассоциация аллергологов и клинических иммунологов, Союз педиатров России, Ассоциация врачей и специалистов медицины труда, Российское респираторное общество. Рубрикатор клинических рекомендаций Минздрава России. 2024. ID: 359_3. Доступ: https://cr.minzdrav.gov.ru/view-cr/359_3 (дата обращения – 17.09.2025). [Clinical guidelines. Bronchial asthma. Russian Association of Allergists and Clinical Immunologists, Union of Pediatricians of Russia, Association of Occupational Medicine Physicians and Specialists, Russian Respiratory Society. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2024. ID: 359_3. Доступ: https://cr.minzdrav.gov.ru/view-cr/359_3 (date of access – 17.09.2025) (In Russ.)].
  3. Бродская О.Н. Коморбидные заболевания при бронхиальной астме. Практическая пульмонология. 2017;(2):3–13. [Brodskaya ON. Comorbidities in patients with asthma. Prakticheskaya pul’monologiya = Practical Pulmonology. 2017;(2):3–13 (In Russ.)]. EDN: ZSHJAP.
  4. Rogliani P, Laitano R, Ora J, Beasley R, Calzetta L. Strength of association between comorbidities and asthma: A meta-analysis. Eur Respir Rev. 2023;32(167):220202. PMID: 36889783. PMCID: PMC10032614. https://doi.org/10.1183/16000617.0202-2022
  5. Кароли Н.А. Коморбидность при бронхиальной астме: так ли это важно и что будет, если лечить не только астму? РМЖ. 2025;9(2):125–132. [Karoli NA. Comorbidity in bronchial asthma: how significant is it, and what are the implications of treating beyond asthma alone? Russkiy meditsisnkiy zhurnal = Russian Medical Inquiry. 2025;9(2):125–132 (In Russ.)]. EDN: NEBEIV. https://doi.org/10.26442/20751753.2022.11.201897
  6. Трофименко И.Н., Черняк Б.А., Цындымеева Д.А. Роль и значение коморбидной патологии при ведении больных бронхиальной астмой. Фарматека. 2025;32(1):137–144. [Trofimenko IN, Chernyak BA, Tsyndymeeva DA. The role and significance of comorbid pathology in the management of patients with bronchial asthma. Farmateka. 2025;32(1):137–144 (In Russ.)]. EDN: XGUDHJ. https://doi.org/10.18565/pharmateca.2025.1.137-144
  7. Чучалин А.Г., Авдеев С.Н., Лещенко И.В. Бронхиальная астма. Руководство для врачей. М.: ГЭОТАР-Медиа, 2023. 384 с. [Chuchalin AG, Avdeev SN, Leshchenko IV. Bronchial asthma. A guide for physicians. Moscow: GEOTAR-Media. 2023; 384 pp. (In Russ.)]. ISBN: 978-5-9704-7654-3.
  8. Овчаренко С.И., Антонов Н.С. Бронхиальная астма: от диагностики к лечению. М.: Атмосфера. 2022; 256 с. [Ovcharenko SI, Antonov NS. Bronchial asthma: From diagnosis to treatment. Moscow: Atmosphere Publishing House. 2022; 256 pp. (In Russ.)]. ISBN: 978-5-901598-89-4.
  9. Boulet LP. Influence of comorbid conditions on asthma. Eur Respir J. 2009;33(4):897–906. PMID: 19336592. https://doi.org/10.1183/09031936.00121308

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2025